BofA Securities analyst Kevin Fischbeck reiterated a Buy rating on HCA Healthcare (NYSE: HCA) and removed the company from the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE